Terms: = Lung cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1
97 results:
1. D-D and PLR, NLR combined forecasting first-line treatment: The short-term curative effect and prognosis of patients with SCLC.
Hu H; Chen WJ; Sun C; Xie JP
Medicine (Baltimore); 2023 Nov; 102(45):e34877. PubMed ID: 37960828
[TBL] [Abstract] [Full Text] [Related]
2. Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With cancer With Different Oral Toxicity Profiles.
Xu Y; Wen N; Haddad RI; Sonis ST; Villa A
Oncologist; 2024 Mar; 29(3):e382-e391. PubMed ID: 37874927
[TBL] [Abstract] [Full Text] [Related]
3. Burden of lung cancer and predicted costs of occupational exposure to hexavalent chromium in the EU - The impact of different occupational exposure limits.
Chen-Xu J; Jakobsen LS; Pires SM; Viegas S
Environ Res; 2023 Jul; 228():115797. PubMed ID: 37001847
[TBL] [Abstract] [Full Text] [Related]
4. New pathogenic germline variants identified in mesothelioma.
Belcaid L; Bertelsen B; Wadt K; Tuxen I; Spanggaard I; Højgaard M; Benn Sørensen J; Ravn J; Lassen U; Cilius Nielsen F; Rohrberg K; Westmose Yde C
Lung Cancer; 2023 May; 179():107172. PubMed ID: 36944283
[TBL] [Abstract] [Full Text] [Related]
5. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract] [Full Text] [Related]
6. The clinicopathological and prognostic significance of mTOR and p-mTOR expression in patients with non-small cell lung cancer: A meta-analysis.
Qiu W; Ren M; Wang C; Fu Y; Liu Y
Medicine (Baltimore); 2022 Dec; 101(51):e32340. PubMed ID: 36595789
[TBL] [Abstract] [Full Text] [Related]
7. Patient specific evaluation of breathing motion induced interplay effects.
Varasteh M; Ali A; Esteve S; Jeevanandam P; Göpfert F; Irvine DM; Hounsell AR; McGarry CK
Phys Med; 2023 Jan; 105():102501. PubMed ID: 36529007
[TBL] [Abstract] [Full Text] [Related]
8. nbn Pathogenic Germline Variants are Associated with Pan-cancer Susceptibility and In Vitro DNA Damage Response Defects.
Belhadj S; Khurram A; Bandlamudi C; Palou-Márquez G; Ravichandran V; Steinsnyder Z; Wildman T; Catchings A; Kemel Y; Mukherjee S; Fesko B; Arora K; Mehine M; Dandiker S; Izhar A; Petrini J; Domchek S; Nathanson KL; Brower J; Couch F; Stadler Z; Robson M; Walsh M; Vijai J; Berger M; Supek F; Karam R; Topka S; Offit K
Clin Cancer Res; 2023 Jan; 29(2):422-431. PubMed ID: 36346689
[TBL] [Abstract] [Full Text] [Related]
9. A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A Decision Curve Analysis.
González Serrano A; Laurent M; Barnay T; Martínez-Tapia C; Audureau E; Boudou-Rouquette P; Aparicio T; Rollot-Trad F; Soubeyran P; Bellera C; Caillet P; Paillaud E; Canouï-Poitrine F
J Clin Oncol; 2023 Feb; 41(4):826-834. PubMed ID: 36306481
[TBL] [Abstract] [Full Text] [Related]
10. Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular models.
Guardiola S; Sánchez-Navarro M; Rosell R; Giralt E; Codony-Servat J
Med Oncol; 2022 Sep; 39(12):195. PubMed ID: 36071367
[TBL] [Abstract] [Full Text] [Related]
11. Mutational landscape of homologous recombination-related genes in small-cell lung cancer.
Wu S; Zhang Y; Zhang Y; Chen LH; Ouyang HF; Xu X; Du Y; Ti XY
Cancer Med; 2023 Feb; 12(4):4486-4495. PubMed ID: 36053931
[TBL] [Abstract] [Full Text] [Related]
12. Gene network Analysis Defines a Subgroup of Small Cell lung cancer patients With Short Survival.
Cucchiara F; Petrini I; Passaro A; Attili I; Crucitta S; Pardini E; de Marinis F; Danesi R; Del Re M
Clin Lung Cancer; 2022 Sep; 23(6):510-521. PubMed ID: 35739016
[TBL] [Abstract] [Full Text] [Related]
13. Radon, Tobacco Exposure and Non-Small Cell lung cancer Risk Related to BER and NER Genetic Polymorphisms.
Enjo-Barreiro JR; Ruano-Ravina A; Pérez-Ríos M; Kelsey K; Varela-Lema L; Torres-Durán M; Parente-Lamelas I; Provencio-Pulla M; Vidal-García I; Piñeiro-Lamas M; Fernández-Villar JA; Barros-Dios JM
Arch Bronconeumol; 2022 Apr; 58(4):311-322. PubMed ID: 35312585
[TBL] [Abstract] [Full Text] [Related]
14. DNA repair and immune checkpoint blockade response.
Guo JA; Alshalalfa M; Kim DY; Hoffman HI; Shiau C; Su J; Hwang WL; Mahal BA
Cancer Genet; 2022 Jun; 264-265():1-4. PubMed ID: 35245846
[TBL] [Abstract] [Full Text] [Related]
15. Ultrasound-sensitive siRNA-loaded nanobubbles fabrication and antagonism in drug resistance for NSCLC.
Su C; Ren X; Yang F; Li B; Wu H; Li H; Nie F
Drug Deliv; 2022 Dec; 29(1):99-110. PubMed ID: 34964410
[TBL] [Abstract] [Full Text] [Related]
16. Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.
de Bono JS; Mehra N; Scagliotti GV; Castro E; Dorff T; Stirling A; Stenzl A; Fleming MT; Higano CS; Saad F; Buttigliero C; van Oort IM; Laird AD; Mata M; Chen HC; Healy CG; Czibere A; Fizazi K
Lancet Oncol; 2021 Sep; 22(9):1250-1264. PubMed ID: 34388386
[TBL] [Abstract] [Full Text] [Related]
17. Magnetic Resonance Imaging Detects Progression of lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis.
Stahl M; Steinke E; Graeber SY; Joachim C; Seitz C; Kauczor HU; Eichinger M; Hämmerling S; Sommerburg O; Wielpütz MO; Mall MA
Am J Respir Crit Care Med; 2021 Oct; 204(8):943-953. PubMed ID: 34283704
[No Abstract] [Full Text] [Related]
18. A situational awareness Bayesian network approach for accurate and credible personalized adaptive radiotherapy outcomes prediction in lung cancer patients.
Luo Y; Jolly S; Palma D; Lawrence TS; Tseng HH; Valdes G; McShan D; Ten Haken RK; Ei Naqa I
Phys Med; 2021 Jul; 87():11-23. PubMed ID: 34091197
[TBL] [Abstract] [Full Text] [Related]
19. FK228 sensitizes radioresistant small cell lung cancer cells to radiation.
Li H; Ma L; Bian X; Lv Y; Lin W
Clin Epigenetics; 2021 Feb; 13(1):41. PubMed ID: 33632300
[TBL] [Abstract] [Full Text] [Related]
20. Therapeutic depletion of CCR8
Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
[TBL] [Abstract] [Full Text] [Related]
[Next]
